Senior Director, Vaccine Clinical Science & Strategy

Merck; Rahway (NJ); Hybrid; USD 250,000 - 420,000; Full time

Benefits offered by this job

Hybrid work model

Competitive compensation

Job summary

Merck in Rahway, NJ is seeking a Senior Director, Clinical Science for Vaccines to provide strategic clinical science leadership across studies and assets. The role partners with cross-functional teams to guide development planning, data interpretation, and governance decisions in a matrix environment.

The position requires deep vaccines expertise, leadership experience, and a focus on standardizing scientific approaches and critical decision-making across the portfolio.

Qualifications

• Significant experience leading Clinical Science across multiple studies and assets.
• Deep therapeutic expertise in vaccines and disease biology.
• Experience guiding development planning and governance discussions.

Responsibilities

• Provide strategic Clinical Science leadership across the disease area and portfolio.
• Lead standardization of Clinical Science approaches and data review practices.
• Provide senior scientific guidance on protocol development, study design, and endpoint selection.
• Contribute to portfolio governance discussions and senior leadership communications.
• Mentor and develop Clinical Scientists in a matrix environment.

Skills

Clinical Development

Clinical Science Leadership

Vaccine Development

Regulatory Submissions

Cross-functional Leadership

Data Interpretation

Biostatistics Collaboration

Executive Communication

Education

Advanced scientific degree (PhD/PharmD) or equivalent

Job description

Merck in Rahway, NJ is seeking a Senior Director, Clinical Science for Vaccines to provide strategic clinical science leadership across studies and assets. The role partners with cross-functional teams to guide development planning, data interpretation, and governance decisions in a matrix environment.

The position requires deep vaccines expertise, leadership experience, and a focus on standardizing scientific approaches and critical decision-making across the portfolio.